Controversial IVF treatment on the way, experts have said

28th April 2011

A controversial IVF treatment which involves moving part of the egg into another donor egg could soon be approved, after scientific review found no evidence that the procedure was unsafe.

Three-parent IVF involved taking the nucleus of a woman's egg, which carries 99 per cent of genetic material, and moving it into another donor before it is implanted in the mother's womb, in a bid to avoid passing on severe inherited genetic conditions which are carried in the cytoplasm around the egg.

The resultant child would still have 99 per cent of their parent's genes, despite the use of the donor.

Organisations in support of the process are now petitioning health secretary Andrew Lansley to draw up regulations so it can be introduced.

Contributor Professor Sir John Bell, president of the Academy of Medical Sciences, said: "We consider it essential that UK patients should benefit from treatments resulting from research conducted here."

Critics have opposed the procedure on ethical grounds, saying that it is just another contributor to the death of hundreds of human embryos which is brought about by IVF.

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.


Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)